Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer

NCT02955758 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Interventions

BIOLOGICAL: Pembrolizumab

Sponsor

Joel Neal

Collaborators

[object Object]